Pacific Biosciences of California (PACB) Insider Trading
- $5,510,920.12
- $123,858,833.16
- March 3, 2026
- Michael Hunkapiller
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Nov. 12, 2020 | Director | 200,000 | $16.73 | Sell | $3,346,000.00 | |
| Nov. 10, 2020 | Director | 1,304,348 | $14.25 | Sell | $18,586,959.00 | |
| Aug. 24, 2020 | CEO | 259,164 | $6.63 | Sell | $1,718,257.32 | |
| Aug. 21, 2020 | CEO | 446,401 | $6.51 | Sell | $2,906,070.51 | |
| March 24, 2020 | SVP | 2,760 | $3.05 | Sell | $8,418.00 | |
| Feb. 20, 2020 | SVP | 5,050 | $4.48 | Sell | $22,624.00 | |
| Feb. 19, 2020 | CFO | 12,558 | $4.44 | Sell | $55,757.52 | |
| Feb. 18, 2020 | CEO | 525,995 | $4.49 | Sell | $2,361,717.55 | |
| Feb. 19, 2019 | CFO | 11,987 | $7.16 | Sell | $85,826.92 | |
| Feb. 19, 2019 | CEO | 13,335 | $7.19 | Sell | $95,878.65 | |
| Feb. 19, 2019 | Director | 6,933 | $7.17 | Sell | $49,709.61 | |
| Feb. 19, 2019 | SVP | 7,231 | $7.17 | Sell | $51,846.27 | |
| Nov. 27, 2018 | Insider | 25,000 | $7.54 | Sell | $188,500.00 | |
| Oct. 28, 2016 | SVP | 20,000 | $8.44 | Sell | $168,800.00 | |
| July 29, 2016 | SVP | 20,000 | $8.45 | Sell | $169,000.00 | |
| April 25, 2016 | SVP | 20,000 | $10.29 | Sell | $205,800.00 | |
| March 2, 2015 | VP | 2,503 | $4.91 | Buy | $12,289.73 | |
| March 2, 2015 | SVP | 2,816 | $4.91 | Buy | $13,826.56 | |
| Aug. 19, 2014 | Director | 39,299 | $5.14 | Buy | $201,996.86 | |
| Aug. 18, 2014 | Director | 135,155 | $5.09 | Buy | $687,938.95 | |
| Aug. 14, 2014 | Director | 77,822 | $5.00 | Buy | $389,110.00 | |
| Aug. 13, 2014 | Director | 29,435 | $4.93 | Buy | $145,114.55 | |
| Aug. 12, 2014 | Director | 123,423 | $4.89 | Buy | $603,538.47 | |
| Dec. 12, 2013 | CEO | 100,000 | $4.13 | Buy | $413,000.00 | |
| Nov. 21, 2013 | CEO | 200,000 | $3.61 | Buy | $722,000.00 | |
| Dec. 3, 2012 | CEO | 154,100 | $1.75 | Buy | $269,675.00 | |
| Nov. 29, 2012 | CEO | 242,200 | $1.68 | Buy | $406,896.00 | |
| Nov. 26, 2012 | CEO | 186,400 | $1.44 | Buy | $268,416.00 | |
| Nov. 20, 2012 | CEO | 155,000 | $1.27 | Buy | $196,850.00 | |
| Nov. 16, 2012 | CEO | 262,300 | $1.16 | Buy | $304,268.00 | |
| Aug. 7, 2012 | CEO | 400,000 | $1.75 | Buy | $700,000.00 |
Insiders are both buying and selling Pacific Biosciences of California stock.
The insider traders at Pacific Biosciences of California are: Michael Hunkapiller, Oene Mark Van, Christian O Henry, Susan G Kim, William W Ericson, Michele Farmer, James Michael Phillips, Kathy Ordonez, Susan K Barnes, Lucy Shapiro, David W Meline, Eric Schaefer, Jeff Eidel, Kevin P Corcoran, Brian B Dow, and Peter Fromen
The most active insider trader at Pacific Biosciences of California is Michael Hunkapiller with 23 trades.
Michael Hunkapiller has sold the most Pacific Biosciences of California stock with a total value of $110,683,981.24.
Michael Hunkapiller has bought the most Pacific Biosciences of California stock with a total value of $3,694,105.00.
The most recent insider trade for Pacific Biosciences of California was on March 3, 2026.
The single biggest insider buy for Pacific Biosciences of California was from Michael Hunkapiller with a total value of $722,000.00 on Nov. 21, 2013.
The single biggest insider sell for Pacific Biosciences of California was from Michael Hunkapiller with a total value of $23,433,882.12 on Jan. 22, 2021.